These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.   

investors@repligen.com

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
3/20/2018
7:30 AM ET
Press Release

Repligen Announces Market Launch of OPUS® 80R, Reinforces Technology Leadership in Pre-Packed Chromatography

3/20/2018

- First and only available 80 cm diameter pre-packed column to address large-scale clinical and commercial-scale manufacturing of biological drugs -

WALTHAM, Mass., March 20, 2018 (GLOBE...

 Continue Reading
2/22/2018
7:30 AM ET
Earnings Release

Repligen Reports Fourth Quarter 2017 Financial Results, Provides Guidance for 2018

2/22/2018

- Revenue for 2017 increased by 35% to $141.2 million (36% at constant currency) -- GAAP EPS for 2017 more than doubled to $0.72, including a positive $0.24 impact of U.S. tax reform -- Spectrum outpe...

 Continue Reading
2/16/2018
7:30 AM ET
Press Release

Repligen to Report Fourth Quarter and Full Year 2017 Financial Results

2/16/2018

WALTHAM, Mass., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report fourth quarter and full year 2017 financial results on Thursday, Feb...

 Continue Reading
12/29/2017
1:47 PM ET
Press Release

Repligen To Present at 36th Annual J.P. Morgan Healthcare Conference

12/29/2017

WALTHAM, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading bioprocessing-focused company delivering technology innovation to improve biologic drug manufacturing...

 Continue Reading
11/9/2017
7:30 AM ET
Earnings Release

Repligen Reports Third Quarter 2017 Financial Results

11/9/2017

Record quarterly revenue of $36.6 million represents 48% year-over-year growthYear-to-date revenue of $99.6 million represents 26% year-over-year growthSpectrum contributes revenue of $7.6 million in...

 Continue Reading
Displaying 1 to 5 (of 209 releases)